Derynck Mika K
Insider CIK 1865125 · ELVN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2026-08-04 | 2026-08-06 | 20,491 | — | $0 | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2026-08-04 | 2026-08-06 | 23,364 | — | $0 | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2026-08-04 | 2026-08-06 | 87,373 | — | $0 | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2026-08-04 | 2026-08-06 | 27,567 | — | $0 | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2026-08-04 | 2026-08-06 | 87,373 | $2.48 | $216.7K | 87,373 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2026-08-04 | 2026-08-06 | 27,567 | $25.28 | $696.9K | 114,940 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2026-08-04 | 2026-08-06 | 23,364 | $14.85 | $347.0K | 138,304 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2026-08-04 | 2026-08-06 | 20,491 | $22.47 | $460.4K | 158,795 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-08-04 | 2026-08-06 | 158,795 | $60.21 | $9.56M | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2026-08-04 | 2026-08-06 | 20,491 | — | $0 | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2026-08-04 | 2026-08-06 | 23,364 | — | $0 | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2026-08-04 | 2026-08-06 | 27,567 | — | $0 | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2026-08-04 | 2026-08-06 | 87,373 | — | $0 | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2026-08-04 | 2026-08-06 | 158,795 | $60.21 | $9.56M | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2026-08-04 | 2026-08-06 | 20,491 | $22.47 | $460.4K | 158,795 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2026-08-04 | 2026-08-06 | 23,364 | $14.85 | $347.0K | 138,304 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2026-08-04 | 2026-08-06 | 27,567 | $25.28 | $696.9K | 114,940 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2026-08-04 | 2026-08-06 | 87,373 | $2.48 | $216.7K | 87,373 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2026-02-12 | 2026-02-17 | 17,126 | — | $0 | 17,126 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2025-02-06 | 2025-02-10 | 20,491 | — | $0 | 20,491 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 16,835 | — | $0 | 16,835 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2024-02-13 | 2024-02-20 | 23,364 | — | $0 | 23,364 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2023-02-23 | 2023-04-06 | 27,567 | — | $0 | 27,567 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2023-02-23 | 2023-02-27 | 87,373 | — | $0 | 87,373 | SEC↗ |